Skip to content

Bausch + Lomb BLCO EV / EBITDA

EV / EBITDA at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
17.2×+0.2×
AbbVie logo
AbbVieABBV
19.8×
Warby Parker logo
Warby ParkerWRBY
55.3×-31.4×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
19.5×+3.6×
Organon logo
OrganonOGN
-1.0×

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Calculated from Bausch + Lomb’s reported figures.

Based on the most recent quarter.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's EV / EBITDA?
Bausch + Lomb (BLCO) reported EV / EBITDA of 16.1× in Q1 2026.
How has Bausch + Lomb's EV / EBITDA changed year-over-year?
Bausch + Lomb's EV / EBITDA decreased by 16.3% year-over-year, from 19.3× to 16.1×.
What is the long-term trend for Bausch + Lomb's EV / EBITDA?
Over 3 years (2022 to 2025), Bausch + Lomb's EV / EBITDA has grown at a 16.2% compound annual growth rate (CAGR), from 13× to 20.3×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.